Strides Pharma relaunches Ranitidine tablets in US
Posted by
www.biotecnika.org
The company had suspended sales of its generic Ranitidine tablets
after the USFDA found contamination in some Ranitidine tablets sold by
various companies with potentially cancer causing impurities, NDMA.
Strides said now the drug meets the limits prescribed by the US drug
regulator.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/strides-pharma-relaunches-ranitidine-tablets-in-us/articleshow/71968842.cms
Subscribe to:
Post Comments (Atom)
Post a Comment